GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 Notes to the Standalone Financial Statements for the year ended March 31, 2022 160 Note 53 : Related Party Disclosures Related party disclosures, as required by IND AS 24, “Related Party Disclosures”, notified under Section 133 of the Companies Act, 2013 are given below: 1 Relationships (during the year): (i) Shareholders (the GlaxoSmithKline (GSK) Group shareholding) in the Company : Glaxo Group Limited, U.K. GlaxoSmithKline Pte Limited, Singapore Eskaylab Limited, U.K. Burroughs Wellcome International Limited, U.K. Holding Group / ultimate holding Group of the above shareholders GlaxoSmithKline Plc, U.K. * GlaxoSmithKline Finance Plc, U.K.* Setfirst Ltd, U.K. * SmithKline Beecham Limited, U.K. Wellcome Limited, U.K.* The Wellcome Foundation Limited, U.K.* Wellcome Consumer Healthcare Limited, U.K.* * no transactions during the year (ii) Subsidiary of the Company : Biddle Sawyer Limited, a wholly owned subsidiary of the Company (iii) Other related parties in the GlaxoSmithKline (GSK) Group where common control exists and with whom the Group had transactions during the year: GlaxoSmithKline Asia Private Limited, India GlaxoSmithKline Biologicals S.A., Belgium GlaxoSmithKline Pharmaceuticals S.A., Belgium* GlaxoSmithKline Services Unlimited, U.K. Glaxo Operations UK Limited, U.K. GlaxoSmithKline Pharmaceutical Sdn Bhd, Malaysia* GlaxoSmithKline Export Limited, U.K. SmithKline Beecham Pharmaceuticals, U.S.A.* GlaxoSmithKline Research & Development Ltd, U.K. GlaxoSmithKline LLC, U.S.A. GlaxoSmithKline Trading Services Limited, Ireland GlaxoSmithKline South Africa (Pty) Ltd, South Africa* GlaxoSmithkline Pharma India Pvt Ltd. GSK India Global Services Private Limited GlaxoSmithKline Pharmaceutical Ltd., Sri Lanka US GMS Financial Services, U.S.A.* GlaxoSmithKline (Thailand) Ltd. GSK Consumer Healthcare (UK) Trading Limited GSK Consumer Healthcare Pte Ltd., Singapore